Protea Biosciences Group Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Protea Biosciences Group Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7844
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Protea Biosciences Group Inc (Protea) is a biotechnology company that develops mass spectometry solutions. The company offers technology for identification, characterization, and quantitation of biologically-important molecules for pharmaceutical development, research, and diagnostic applications. Its products include functionalized pipette tips and plates, gel protein separation and recovery, protein sample preparation, amplus HPLC columns and mass spectrometry standards, among others. Protea’s services include bioanalytical services and mass spec imaging services. The company’s bioanalytical services include biomarker discovery, advanced proteomics and protein, biotherapeutic characterization and peptide quantitation, among others. It also provides label free imaging, translational, and drug and metabolite distribution. The company serves pharmaceutical, clinical, academic and industrial research. Protea is headquartered in Morgantown, West Virginia, the US.

Protea Biosciences Group Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Protea Biosciences Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Protea Biosciences Group Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Protea Biosciences Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Protea Biosciences Group Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Protea Biosciences Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Protea Biosciences Group Inc, Medical Equipment, Deal Details 11
Partnerships 11
Protea Biosciences Enters into Licensing Agreement with Yale University 11
Protea Biosciences Enters into Research Agreement with Vaccine and Immunotherapy Center 12
Protea Biosciences Enters into Agreement with Massachusetts General Hospital 13
Protea Biosciences Extends Partnership with Protein Metrics 14
Protea Biosciences Enters into Agreement with Agilent Technologies 15
Protea Biosciences Enters into Agreement with InSphero for 3D Technologies 16
Protea Biosciences Enters Into Research Agreement With Virginia Commonwealth University For Molecular Imaging Techniques 17
Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group For LASEI DP-1000 18
Equity Offering 19
Protea Biosciences Files Registration Statement to Raise up to USD17.3 Million in Public Offering of Shares 19
Protea Biosciences Group Raises USD0.6 Million in Private Placement 20
Protea Biosciences to Raise Funds through Public Offering of Shares 21
Protea Biosciences Raises USD0.98 Million in Public Offering of Units 22
Protea Biosciences Raises USD2.53 Million in Public Offering of Units 23
Protea Biosciences Group Completes Private Placement Of Shares For US$0.7 Million 24
Protea Biosciences Completes Private Placement Of Shares For US$0.5 Million 25
Debt Offering 26
Protea Biosciences Raises USD0.1 Million in Private Placement of Debentures 26
Protea Biosciences Raises USD1.61 Million in Private Placement of Debentures 27
Protea Biosciences Raises USD2 Million in Private Placement of Debentures 28
Protea Biosciences Group Completes Private Placement Of Debt Securities For US$0.3 Million 29
Asset Transactions 30
Purdue University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 30
Princeton University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 31
United States Department of Agriculture Acquires Laesi DP-1000 from Protea Biosciences 32
Protea Biosciences Group Inc – Key Competitors 33
Protea Biosciences Group Inc – Key Employees 34
Protea Biosciences Group Inc – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Financial Announcements 36
Apr 18, 2017: Protea Announces 2016 Year End Results 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
Protea Biosciences Group Inc, Medical Equipment, Key Facts 2
Protea Biosciences Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Protea Biosciences Group Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Protea Biosciences Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Protea Biosciences Group Inc, Deals By Market, 2012 to YTD 2018 8
Protea Biosciences Group Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Protea Biosciences Enters into Licensing Agreement with Yale University 11
Protea Biosciences Enters into Research Agreement with Vaccine and Immunotherapy Center 12
Protea Biosciences Enters into Agreement with Massachusetts General Hospital 13
Protea Biosciences Extends Partnership with Protein Metrics 14
Protea Biosciences Enters into Agreement with Agilent Technologies 15
Protea Biosciences Enters into Agreement with InSphero for 3D Technologies 16
Protea Biosciences Enters Into Research Agreement With Virginia Commonwealth University For Molecular Imaging Techniques 17
Waters Enters Into Co-Marketing Agreement With Protea Biosciences Group For LASEI DP-1000 18
Protea Biosciences Files Registration Statement to Raise up to USD17.3 Million in Public Offering of Shares 19
Protea Biosciences Group Raises USD0.6 Million in Private Placement 20
Protea Biosciences to Raise Funds through Public Offering of Shares 21
Protea Biosciences Raises USD0.98 Million in Public Offering of Units 22
Protea Biosciences Raises USD2.53 Million in Public Offering of Units 23
Protea Biosciences Group Completes Private Placement Of Shares For US$0.7 Million 24
Protea Biosciences Completes Private Placement Of Shares For US$0.5 Million 25
Protea Biosciences Raises USD0.1 Million in Private Placement of Debentures 26
Protea Biosciences Raises USD1.61 Million in Private Placement of Debentures 27
Protea Biosciences Raises USD2 Million in Private Placement of Debentures 28
Protea Biosciences Group Completes Private Placement Of Debt Securities For US$0.3 Million 29
Purdue University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 30
Princeton University Acquires LAESI DP-1000 Instrument System from Protea Biosciences 31
United States Department of Agriculture Acquires Laesi DP-1000 from Protea Biosciences 32
Protea Biosciences Group Inc, Key Competitors 33
Protea Biosciences Group Inc, Key Employees 34
Protea Biosciences Group Inc, Subsidiaries 35

List of Figures
Protea Biosciences Group Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Protea Biosciences Group Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Protea Biosciences Group Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Protea Biosciences Group Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Protea Biosciences Group Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Protea Biosciences Group Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Morphogenesis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Morphogenesis Inc (Morphogenesis) is a novel cell and gene therapies developer. The company manufactures products based on distinct and synergistic technology platforms. It uses technologies such as immunefx cancer immunotherapies, the polymer antibody cell separation device, morphogenesis’ …
  • Sanford Burnham Prebys Medical Discovery Institute-製薬・医療分野:企業M&A・提携分析
    Summary Sanford Burnham Prebys Medical Discovery Institute (Sanford Burnham) is a non-profit public benefit institute that offers medical research services. The institute offers research programs in the field of tumor initiation and maintenance, cancer metabolism and signaling networks, tumor microe …
  • Keyence Corporation:企業の戦略・SWOT・財務分析
    Keyence Corporation - Strategy, SWOT and Corporate Finance Report Summary Keyence Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Spaulding Clinical Research LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Spaulding Clinical Research LLC (Spaulding Clinical Research) is a CRO providing Phase I - IV drug development services to biotechnologyand pharmaceutical companies. The company provides spaulding electrocardiograph and spauldingwebECG. It provides data management services which such as eCRF …
  • Fagron NV:企業のM&A・事業提携・投資動向
    Fagron NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fagron NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Shield Therapeutics Plc (STX):企業の財務・戦略的SWOT分析
    Summary Shield Therapeutics Plc (Shield Therapeutics) is a specialty pharmaceutical company that focus on the development and commercialization products for the treatment of anaemia associated with renal and gastrointestinal disorders. The company’s product portfolio includes Feraccru, a stable, non …
  • Clearside BioMedical Inc (CLSD):企業の財務・戦略的SWOT分析
    Summary Clearside BioMedical Inc (Clearside) is a clinical biopharmaceutical company that develops treatments for vision impairment associated with uveitic macular edema. The company’s pipeline products comprise Uveitis, macular edema associated with non- infectious uveitis; RVO - Retinal Vein Occlu …
  • Securitas AB (SECU B):企業の財務・戦略的SWOT分析
    Securitas AB (SECU B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TTCL Public Company Limited (TTCL):電力:M&Aディール及び事業提携情報
    Summary TTCL Public Company Limited (TTCL), a subsidiary of Italian-Thai Development Public Company Limited, is a provider of engineering and construction services. The company offers integrated engineering, procurement and construction (EPC) services, feasibility study and project management servic …
  • Advantage Oil & Gas Ltd (AAV):石油・ガス:M&Aディール及び事業提携情報
    Summary Advantage Oil & Gas Ltd (Advantage Oil & Gas) is an upstream company. It is involved in exploitation, acquisition, development, and production of crude oil, natural gas and natural gas liquids in Alberta. The company’s exploitation and development program is focused on Glacier assets and the …
  • Medpace Holdings Inc (MEDP):企業の財務・戦略的SWOT分析
    Medpace Holdings Inc (MEDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Themis Medicare Ltd (THEMISMED):企業の財務・戦略的SWOT分析
    Summary Themis Medicare Ltd (Themis Medicare), a subsidiary of Gedeon Richter Plc is a differentiated injectables developer that manufactures and markets pharmaceutical and healthcare products. The company’s products include formulations, original products, active pharmaceutical ingredients and diet …
  • Targa Resources Corp (TRGP):石油・ガス:M&Aディール及び事業提携情報
    Summary Targa Resources Corp (Targa) is an independent midstream oil and gas company that offers midstream services. The company’s business activities include gathering, compressing, treating, processing, and selling natural gas; storing, fractionating, treating, transporting, and selling natural ga …
  • Resonance Health Ltd (RHT):企業の財務・戦略的SWOT分析
    Summary Resonance Health Ltd (Resonance Health) is a healthcare solution provider that offers non-invasive medical imaging software and services. The company offers FerriScan analysis software for the measurement of liver iron concentration (LIC); FerriScan with Cardiac T2* dual analysis service to …
  • Trane Technologies Plc (TT):企業の財務・戦略的SWOT分析
    Trane Technologies Plc (TT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Noble Group Ltd:企業のM&A・事業提携・投資動向
    Noble Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Noble Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Bioverativ Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant antihemophilic factor engineered using Fc fusion technolog …
  • ICL Group Ltd (ICL):企業の財務・戦略的SWOT分析
    ICL Group Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Ship Finance International Ltd (SFL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ship Finance International Ltd (Ship Finance International) is a provider of bulker, tanker, container, and offshore solutions. The company offers fleet of vessels such as crude oil tankers for ultra-deep water semi-submersible dry bulk carriers and drilling rigs, among others. It also opera …
  • California Institute for Biomedical Research:製薬・医療:M&Aディール及び事業提携情報
    Summary California Institute for Biomedical Research (Calibr) is a not for profit organization that offers translational research. The organization discovers and develops therapies for unmet medical needs. It conducts research in the human disease areas of degenerative and age-related diseases, canc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆